Dear E,

The J.P. Morgan Healthcare Conference is in less than two weeks and there are still a few spots open to attend our FierceBiotech Executive Breakfast on January 14th. The event will run from 7:00AM-11:30AM at The Fairmont Hotel in San Francisco and will include a full breakfast buffet, two panels with visionary speakers, a closing reception sponsored by Clarivate, networking, and more.

This year's speaker lineup includes:

Panel One / Strategic Considerations for the Commercialization of Cell and Gene Therapies:

• Dr. Mitchell Finer / Chief Scientific Officer / ElevateBio
• David J. Lennon, Ph.D. / President / AveXis, a Novartis Company
• Paul Levesque / Global President of Pfizer Rare Disease / Pfizer
• Bill Martin / Chief Commercial Officer / Accredo and Curascript SD
• Opening Remarks: Keiko Oishi / President and COO / CMIC
• Alberto Santagostino / Head of Cell and Gene Technologies / Lonza
• Closing Remarks: Stephen J. Ubl / President and Chief Executive Officer / PhRMA
  

Panel Two / The Promise of AI: Can Artificial Intelligence and Machine Learning Really Transform R&D?

• Chris Gibson, Ph.D. / Co-Founder and CEO / Recursion Pharmaceuticals
• Kevin Julian / Senior Managing Director, Life Sciences / Accenture
• Daphne Koller / CEO and Founder / Insitro
• Christopher McKenna / Global Head of Professional Services & Consulting / Clarivate Analytics
• Melanie Nallicheri / Life Sciences Executive, Former Chief Business Officer and Head / Biopharma, Foundation Medicine; Former SVP, Corporate Strategy and Business Development / McKesson
• Opening Remarks: Sajith Wickramasekara / CEO and Co-Founder / Benchling
  
• Alex Zhavoronkov, PhD / Founder and CEO / Insilico Medicine

Registration for the event is available here. I look forward to seeing you in San Francisco.

Best,

Rebecca Willumson
Publisher
FierceBiotech & FiercePharma